Toronto, ON – August, 2018 – DW Healthcare Partners (“DWHP”), a healthcare-focused private equity firm, announced the sale of its portfolio company, PRIME Education (PRIME®) to a strategic buyer. PRIME is a nationally recognized medical education and outcomes research company known for its award-winning, systems-based work and extensive peer-reviewed publications in health care.
DWHP invested in PRIME in November of 2016. The sale marks the first realization for DWHP’s fourth equity fund. The fund is a $294 million investment vehicle with 64% of capital invested.
“I am proud of the progress we have made at PRIME and grateful for the support of DW Healthcare Partners,” noted CEO Kathleen Moreo. “In a short period of time, our success at disseminating important evidence-based education and research findings has grown tremendously, impacting improved health outcomes.”
Managing Partner of DWHP Andrew Carragher stated, “The leadership at PRIME has shown that they can set big goals and implement towards them successfully. In the two years they have worked with us, we have seen them create new strategies, products, and revenue streams to take their business to the next level. They truly are a fantastic team.”
ABOUT DW HEALTHCARE PARTNERS
DW Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. The firm manages over $800 million in committed capital and invests in profitable healthcare companies with proven management teams.
DW Healthcare Partners is led by seasoned healthcare executives with more than 110 years of combined industry experience. The firm provides the capital, strategic guidance, and acquisition expertise to help mid-to-late-stage companies realize their potential for growth.
